Cargando…

Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap

Tolerance induction and desensitization in Stevens–Johnson syndrome (SJS) or in toxic epidermal necrolysis (TEN) have been described as an absolute contraindication by some authors, but there are cases where there is no treatment alternative. Tuberculosis (TB) remains a leading cause of morbidity an...

Descripción completa

Detalles Bibliográficos
Autores principales: Collado-Chagoya, Rodrigo, Hernández-Romero, Javier, Eliosa-Alvarado, Gumaro A., Cruz-Pantoja, Rubén A., Campos-Gutiérrez, Rosa I., Velasco-Medina, Andrea A., Velázquez-Sámano, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071158/
https://www.ncbi.nlm.nih.gov/pubmed/30083412
http://dx.doi.org/10.1177/2152656718783618
_version_ 1783343820732104704
author Collado-Chagoya, Rodrigo
Hernández-Romero, Javier
Eliosa-Alvarado, Gumaro A.
Cruz-Pantoja, Rubén A.
Campos-Gutiérrez, Rosa I.
Velasco-Medina, Andrea A.
Velázquez-Sámano, Guillermo
author_facet Collado-Chagoya, Rodrigo
Hernández-Romero, Javier
Eliosa-Alvarado, Gumaro A.
Cruz-Pantoja, Rubén A.
Campos-Gutiérrez, Rosa I.
Velasco-Medina, Andrea A.
Velázquez-Sámano, Guillermo
author_sort Collado-Chagoya, Rodrigo
collection PubMed
description Tolerance induction and desensitization in Stevens–Johnson syndrome (SJS) or in toxic epidermal necrolysis (TEN) have been described as an absolute contraindication by some authors, but there are cases where there is no treatment alternative. Tuberculosis (TB) remains a leading cause of morbidity and mortality in developing countries and ranks alongside HIV as a leading cause of death worldwide. Severe drug reactions, such as SJS and TEN, occurring in these individuals are lifethreatening. Since alternative therapies for TB are limited, the role of desensitization and reintroduction becomes essential. We describe a case of tolerance induction to anti-TB drugs in a patient with SJS/TEN overlap syndrome using a specifically designed premedication, comedication, and desensitization protocol.
format Online
Article
Text
id pubmed-6071158
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-60711582018-08-06 Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Collado-Chagoya, Rodrigo Hernández-Romero, Javier Eliosa-Alvarado, Gumaro A. Cruz-Pantoja, Rubén A. Campos-Gutiérrez, Rosa I. Velasco-Medina, Andrea A. Velázquez-Sámano, Guillermo Allergy Rhinol (Providence) Article Tolerance induction and desensitization in Stevens–Johnson syndrome (SJS) or in toxic epidermal necrolysis (TEN) have been described as an absolute contraindication by some authors, but there are cases where there is no treatment alternative. Tuberculosis (TB) remains a leading cause of morbidity and mortality in developing countries and ranks alongside HIV as a leading cause of death worldwide. Severe drug reactions, such as SJS and TEN, occurring in these individuals are lifethreatening. Since alternative therapies for TB are limited, the role of desensitization and reintroduction becomes essential. We describe a case of tolerance induction to anti-TB drugs in a patient with SJS/TEN overlap syndrome using a specifically designed premedication, comedication, and desensitization protocol. SAGE Publications 2018-08-01 /pmc/articles/PMC6071158/ /pubmed/30083412 http://dx.doi.org/10.1177/2152656718783618 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Collado-Chagoya, Rodrigo
Hernández-Romero, Javier
Eliosa-Alvarado, Gumaro A.
Cruz-Pantoja, Rubén A.
Campos-Gutiérrez, Rosa I.
Velasco-Medina, Andrea A.
Velázquez-Sámano, Guillermo
Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap
title Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap
title_full Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap
title_fullStr Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap
title_full_unstemmed Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap
title_short Tolerance Induction to Antituberculosis Drugs in a Patient With Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap
title_sort tolerance induction to antituberculosis drugs in a patient with stevens–johnson syndrome/toxic epidermal necrolysis overlap
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071158/
https://www.ncbi.nlm.nih.gov/pubmed/30083412
http://dx.doi.org/10.1177/2152656718783618
work_keys_str_mv AT colladochagoyarodrigo toleranceinductiontoantituberculosisdrugsinapatientwithstevensjohnsonsyndrometoxicepidermalnecrolysisoverlap
AT hernandezromerojavier toleranceinductiontoantituberculosisdrugsinapatientwithstevensjohnsonsyndrometoxicepidermalnecrolysisoverlap
AT eliosaalvaradogumaroa toleranceinductiontoantituberculosisdrugsinapatientwithstevensjohnsonsyndrometoxicepidermalnecrolysisoverlap
AT cruzpantojarubena toleranceinductiontoantituberculosisdrugsinapatientwithstevensjohnsonsyndrometoxicepidermalnecrolysisoverlap
AT camposgutierrezrosai toleranceinductiontoantituberculosisdrugsinapatientwithstevensjohnsonsyndrometoxicepidermalnecrolysisoverlap
AT velascomedinaandreaa toleranceinductiontoantituberculosisdrugsinapatientwithstevensjohnsonsyndrometoxicepidermalnecrolysisoverlap
AT velazquezsamanoguillermo toleranceinductiontoantituberculosisdrugsinapatientwithstevensjohnsonsyndrometoxicepidermalnecrolysisoverlap